Clinical trials
Fibrosis trials in Spain with no applicable phase
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
14 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2010 | 1 |
| 2011 | 2 |
| 2015 | 1 |
| 2017 | 2 |
| 2020 | 1 |
| 2021 | 1 |
| 2022 | 2 |
| 2023 | 1 |
| 2024 | 1 |
| 2025 | 1 |
| 2026 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 9 |
| Recruiting | 2 |
| Withdrawn | 2 |
| Terminated | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau | 4 |
| Fundación Pública Andaluza para la gestión de la Investigación en Sevilla | 2 |
| Consorci Sanitari de l'Alt Penedès i Garraf | 1 |
| Echosens | 1 |
| Fundacio Privada Mon Clinic Barcelona | 1 |
| Hospital General Universitario de Alicante | 1 |
| Hospital Universitari Vall d'Hebron Research Institute | 1 |
| Instituto Aragones de Ciencias de la Salud | 1 |
| Instituto Grifols, S.A. | 1 |
| University of Salamanca | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Fibrosis | 14 |
| Hypertension, Portal | 3 |
| Liver Cirrhosis | 2 |
| Sarcopenia | 2 |
| Diabetes Mellitus | 1 |
| Frailty | 1 |
| Hepatitis C, Chronic | 1 |
| Liver Failure | 1 |
| Malnutrition | 1 |
| Neuroinflammatory Diseases | 1 |
Trials
Showing 1 to 14 of 14. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.